The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of a triazole class of highly potent Porcn inhibitors.EBI
Ut Southwestern Medical Center
Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold.EBI
Soochow University
The use of porcupine inhibitors to target Wnt-driven cancers.EBI
Experimental Therapeutics Centre
The development of highly potent inhibitors for porcupine.EBI
The University of Texas Southwestern Medical Center
Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors.EBI
Genomics Institute of The Novartis Research Foundation
Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.EBI
Soochow University